A long-term 0.03% tacrolimus ointment based regimen comprising of up to 6 weeks of initial twice daily treatment and subsequent twice weekly prophylactic application can effectively treat active lesions of atopic dermatitis, and prevent, delay, and reduce flares.

Inclusion Criteria:

• Male or female patient of any ethnic group
• Patient was at least 2-15 years old and suffered from mild to severe atopic dermatitis (Rajka/Langeland score of at least 3)

Exclusion Criteria:

• Patient had a genetic epidermal barrier defect such as Netherton's syndrome or generalised erythroderma
• Patient had a clinically significant skin infection on the affected (and to be treated) area